Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 51655-193

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 51655-193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (51655 193 26)

Label (51655 193 26)
This is a description of Metoprolol Succinate Extended-Release Tablets, USP with a strength of 100mg. The package contains 90 tablets and should be stored within the temperature range of 25°C (77°F) with excursions permitted to 75°-30°C (55°-86°F). It is an Rx only medication and each film-coated tablet contains 95mg of metoprolol succinate, which is equivalent to 100mg of metoprolol tartrate, USP. The medication is repackaged by Northwind Pharmaceuticals from Teva Phamacuticals USA, Inc. This package is manufactured in Indianapolis, IN 46203, and has a GTIN of 0035165519326. It also includes relevant information like LCN, REV number, S/N, EXP date, and LOT number.*
FDA Label Image

2 (Image 5)

2 (Image 5)
FDA Label Image

1 (Image 6)

1 (Image 6)
FDA Label Image

1 (Image 9)

1 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.